Related Experiment Video
Updated: Jun 19, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Pacemaker and defibrillator therapy in pediatrics and congenital heart disease
1University of Washington School of Medicine, Children's Heart Center G-0035, Children's Hospital & Regional Medical Center, 4800 Sand Point Way NE, Seattle, WA 98105, USA. terrence.chun@seattlechildrens.org
Insights
Pacemakers and implantable cardioverter-defibrillators (ICDs) are increasingly used in pediatric patients with congenital heart disease. However, their efficacy and management present unique challenges requiring individualized approaches and novel technical solutions.
Area of Science:
- Cardiology
- Pediatric Electrophysiology
- Medical Device Technology
Background:
- Pacemaker and defibrillator use is expanding in pediatric populations, including those with congenital heart disease.
- Rhythm disturbances are prevalent in these patients, yet device therapy efficacy is not fully established.
- The unique physiology of pediatric patients and congenital heart disease complicates device management.
Purpose of the Study:
- To review current guidelines and indications for implantable device therapy in children and congenital heart disease patients.
- To highlight the specific challenges and limitations encountered in device implantation and follow-up for this population.
- To discuss the need for individualized management and novel approaches in pediatric device therapy.
Main Methods:
- Review of current literature and clinical guidelines.
- Analysis of technical challenges in device and lead implantation in pediatric patients.
- Discussion of individualized management strategies for congenital heart disease patients requiring pacemakers or defibrillators.
Main Results:
- Current guidelines and indications for pediatric device therapy are presented.
- Technical difficulties with device and lead implantation necessitate innovative solutions.
- Device management in this complex population requires a highly individualized approach.
Conclusions:
- Implantable device therapy in pediatric patients with congenital heart disease presents unique challenges.
- Novel approaches and individualized management are crucial for successful implantation and follow-up.
- Further research is needed to establish the efficacy of device therapy in these specific patient groups.
Abstract:
Pacemakers and defibrillators have a growing use in pediatrics and in patients with congenital heart disease, but they present unique problems and implications for their implantation and follow-up. Congenital and surgically acquired rhythm disturbances are common, but the efficacy of device therapy is not well established in these patient groups. The diversity and complexity of pediatric patients and congenital heart disease make device management a highly individualized art. There are technical issues related to device implantation that have necessitated novel approaches to using leads and device that were not designed with children specifically in mind. The current guidelines and indications for implantable device therapy for children and congenital heart disease are reviewed, as well as some of the specific limitations and problems encountered.
Related Concept Videos
Dysrhythmias VI: Management of Dysrhythmias
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Cardiopulmonary Resuscitation III: AED Use
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
